116 related articles for article (PubMed ID: 1483933)
1. Lack of allelic preference in amplification and loss of the c-myc oncogene in methylcholanthrene-induced mouse sarcomas.
Niwa O; Kominami R
Jpn J Cancer Res; 1992 Nov; 83(11):1192-7. PubMed ID: 1483933
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
[TBL] [Abstract][Full Text] [Related]
3. Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas.
Niwa O; Kamiya K; Furihata C; Nitta Y; Wang Z; Fan YJ; Ninomiya Y; Kotomura N; Numoto M; Kominami R
Cancer Res; 1995 Dec; 55(23):5670-6. PubMed ID: 7585652
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas.
Shimokado K; Watanabe H; Sumii M; Miyagawa K; Kamiya K; Dohi K; Niwa O
Jpn J Cancer Res; 1998 Mar; 89(3):269-77. PubMed ID: 9600120
[TBL] [Abstract][Full Text] [Related]
5. Overexpression and amplification of the c-myc gene in mouse tumors induced by chemicals and radiations.
Niwa O; Enoki Y; Yokoro K
Jpn J Cancer Res; 1989 Mar; 80(3):212-8. PubMed ID: 2470712
[TBL] [Abstract][Full Text] [Related]
6. Motif-primed polymerase chain reaction-based allelotype of sarcomas induced by 3-methylcholanthrene in interspecific hybrid mice.
Dudley ME; Sundberg JP; Roopenian DC
Oncogene; 1995 Aug; 11(3):517-24. PubMed ID: 7630636
[TBL] [Abstract][Full Text] [Related]
7. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
8. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Cheng JM; Hiemstra JL; Schneider SS; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Nat Genet; 1993 Jun; 4(2):191-4. PubMed ID: 8102299
[TBL] [Abstract][Full Text] [Related]
9. Distribution of radiolabeled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcoma.
Buchsbaum DJ; Walker PC; Johnson EA
Cancer Res; 1979 Sep; 39(9):3363-8. PubMed ID: 476667
[TBL] [Abstract][Full Text] [Related]
10. Serological analysis of cell surface antigens on methylcholanthrene-induced mouse sarcomas with antisera produced against the tumors.
Tanimoto M; Takahashi T; Nishizuka Y
Gan; 1982 Apr; 73(2):184-92. PubMed ID: 6288499
[TBL] [Abstract][Full Text] [Related]
11. Alterations of mouse proto-oncogenes in sarcomas induced after transplantation of human tumors in athymic nude mice.
Yuasa Y; Yamazaki H; Maruo K; Ueyama Y; Shibuya M; Tamaoki N
Jpn J Cancer Res; 1990 Apr; 81(4):333-9. PubMed ID: 2114387
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
13. No association between c-myc amplification and TP53 mutation in sarcoma tumorigenesis.
Castresana JS; Barrios C; Gómez L; Kreicbergs A
Cancer Genet Cytogenet; 1994 Aug; 76(1):47-9. PubMed ID: 8076351
[TBL] [Abstract][Full Text] [Related]
14. c-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms.
Barrios C; Castresana JS; Falkmer UG; Rosendahl I; Kreicbergs A
Int J Cancer; 1994 Sep; 58(6):781-6. PubMed ID: 7927868
[TBL] [Abstract][Full Text] [Related]
15. Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver.
Vorce RL; Goodman JI
J Toxicol Environ Health; 1991 Nov; 34(3):385-95. PubMed ID: 1942124
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and amplification of c-myc during progression of human colorectal cancer.
Rochlitz CF; Herrmann R; de Kant E
Oncology; 1996; 53(6):448-54. PubMed ID: 8960139
[TBL] [Abstract][Full Text] [Related]
18. Hgfr/Met oncogene acts as target for gene amplification in DMBA-induced rat sarcomas: free chromatin fluorescence in situ hybridization analysis of amplicon arrays in homogeneously staining regions.
Helou K; Walentinsson A; Kost-Alimova M; Levan G
Genes Chromosomes Cancer; 2001 Apr; 30(4):416-20. PubMed ID: 11241796
[TBL] [Abstract][Full Text] [Related]
19. Differences in c-myc and pvt-1 amplification in SEWA sarcoma sublines selected for adherent or non-adherent growth.
Minarovits J; Steinitz M; Boldog F; Imreh S; Wirschubsky Z; Ingvarsson S; Hedenskog M; Minarovits-Kormuta S; Klein G
Int J Cancer; 1990 Mar; 45(3):514-20. PubMed ID: 2307540
[TBL] [Abstract][Full Text] [Related]
20. Association between immunoglobulin and macrophages in primary methylcholanthrene-induced sarcomas.
Wood GW; Tilzer SA; Gollahon KA; Lindsay JM
Cancer Res; 1979 Nov; 39(11):4588-93. PubMed ID: 498089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
